Increasing the Efficiency of Depression-screening Using Patient-targeted Feedback (DEPSCREEN-INFO)

Universitätsklinikum Hamburg-Eppendorf

Status: Completed

Conditions: Hypertension; Chronic Ischaemic Heart Disease; Depressive Episode

Treatments: Other: patient-targeted feedback

Study type: Interventional

Funder types: Other

Identifiers

NCT01879111

01-GX-1004

DRKS00003277 (Registry Identifier)

Details and patient eligibility

About

Out-patients with coronary heart disease or hypertension will fill out a depression screening questionnaire while waiting in a cardiac clinic. Using a randomised-controlled study design half of the patients will receive a patient-targeted written screening feedback. This feedback contains information about depression in general, depression-severity adapted treatment guidelines and contact-information for treatment. Patients in the control group receive no direct screening-feedback but their cardiologist will be informed about the screening result. All patients with a positive screening-result will be contacted after one month and six months and asked for symptoms of depression, and their use of health care. The aim of this study is to evaluate the efficiency of this minimal intervention on the course of depressive symptom in patients with known coronary heart disease or hypertension.

Full description

The aim of this study is to evaluate the efficiency of a minimal intervention on the course of depressive symptoms in patients with known coronary heart disease (CHD) or hypertension. By means of a depression screening and individual patient-targeted feedback the level of depression should decrease, the percentage of treated depressed patients should increase and health economic costs should be lowered. The main hypothesis is that screening plus targeted feedback results in a greater reduction of depression than screening only.

Enrollment: 4,151 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Gender: Both, male and female
• Minimum Age: 18 Years
• Maximum Age: no maximum age
• Attendance in a cardiac clinic;
• Clinical diagnosis of coronary heart disease or hypertension;
• Age ≥ 18 years;
• Sufficient language skills;
• Informed consent

Exclusion criteria

• Life threatening health status;
• Severe somatic or/and psychological disorder that needs urgent treatment;
• Acute suicidal tendency;
• Severe cognitive or/and visual difficulties;
• Not being able to fill out questionnaires

Trial design

Primary purpose: Screening

Allocation: Randomized

Interventional model: Factorial Assignment

Masking: Single Blind

---

4,151 participants in 2 patient groups

state-of-art depression screening + patient-targeted feedback

Experimental group

Description:

Using a randomised-controlled study design half of the patients will receive a patient-targeted written screening feedback. This feedback contains information about depression in general, depression-severity adapted treatment guidelines and contact-information for treatment.

Treatment:

Other: patient-targeted feedback

state-of-art depression screening

No Intervention group